COLORECTAL CANCER IS THE SECOND LEADING CAUSE OF CANCER RELATED DEATHS IN LOUISIANA, AND NOW A WELL KNOWN ACTOR IS URGING ALL ...
The University of Colorado Cancer Center at CU Anschutz has been selected by the National Cancer Institute as one of just ...
Living in rural Colorado means long days, hard work, and taking care of the people and land we love. Whether you’re tending crops, working cattle, raising a family, or enjoying retirement, ...
A telehealth company that generated buzz last year with a defiant Super Bowl ad hawking weight-loss drugs is back for this ...
Telehealth company Hims & Hers has added a blood test to its offerings. Galleri created the Grail blood test to detect a range of cancers. It’s designed to be used in addition to seeing your ...
Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & ...
Grail has filed for Food and Drug Administration approval of its multi-cancer early detection test, the company said Thursday ...
Guardant Health, Inc. , a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the largest study ...
Guardant Health snagged the FDA green light to use its Guardant360 CDx colon cancer diagnostic along with Pfizer’s colon and skin cancer drug Braftovi in combination with cetuximab and chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results